Etzer Darout

Stock Analyst at BMO Capital

(1.33)
# 1747
Out of 5,249 analysts
119
Total ratings
37.66%
Success rate
10.72%
Average return
36 Stocks
Name Action Price Target Current % Upside Ratings Updated
IGM Biosciences
Downgrades: Market Perform
21 2
1.71 16.96% 2 Jan 10, 2025
Exelixis
Downgrades: Market Perform
36 40
33.8 18.34% 3 Dec 20, 2024
Q32 Bio
Maintains: Outperform
64 22
3.36 554.76% 2 Dec 12, 2024
Tourmaline Bio
Initiates Coverage On: Outperform
50
17.25 189.86% 1 Dec 6, 2024
Protagonist Therapeu...
Initiates Coverage On: Outperform
62
37.78 64.11% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
35
19.89 75.97% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
55
44.54 23.48% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
63
6.07 937.89% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
90 88
18.23 382.72% 2 Nov 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
28 27
5.54 387.36% 7 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
132 134
82.42 62.58% 6 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
32 34
20.97 62.14% 5 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
46 48
21.28 125.56% 3 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
118 120
99.71 20.35% 3 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 38
45.4 -16.3% 3 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
19 26
4.67 456.75% 4 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 25
6.34 294.32% 6 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
8 5
3.16 58.23% 9 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
20 20
3.77 430.5% 3 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
84 91
41.13 121.25% 5 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
7 6
1.34 347.76% 7 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
4 4
0.86 317.44% 10 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
123 122
120.79 1% 3 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
80 82
68.61 19.52% 4 Apr 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
31
n/a n/a 4 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12
2.49 381.93% 2 Sep 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 19
4.39 332.8% 2 Apr 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
179 229
n/a n/a 4 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
170
273.22 -37.78% 2 Feb 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
84
8.34 907.19% 1 Jul 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
n/a n/a 1 May 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
38
n/a n/a 5 Mar 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
54
25.44 112.26% 1 Feb 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Sep 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 38
48.95 -22.37% 2 Sep 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 52
2.55 1939.22% 1 Mar 28, 2018